West nile virus vaccine and method of use thereof
US11135281B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 7, 2017 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Jul 7, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A West Nile virus (WNV) vaccine for human use is described that contains a recombinantly produced form of truncated WNV envelope glycoprotein and a combination of a Toll-like receptor 4 (TLR-4) and saponin adjuvants. A pharmaceutically acceptable vehicle may also be included in the vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.